RaQualia Pharma Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY18.32 |
Market Cap |
JPY31.38 B |
Shares Outstanding |
20.39 M |
Public Float |
16.87 M |
Address |
Daiwa Meieki Building, 8/F Nagoya Aichi 450 Japan |
Employees | - |
Website | http://www.raqualia.co.jp |
Updated | 09/14/2018 |
RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. Its medicines focus on pain, gastrointestinal, auto-immune diseases, inflammation, cancer, and Alzheimer's. Its products include Anidulafungin, Dalbavancin, Ziprasidone, 5-HT4 Partial Agonist, and 5-HT2B Antagonist. |